combination of eribulin and capecitabine provides clinical benefit for women with mbc
Published 9 years ago • 216 plays • Length 6:06Download video MP4
Download video MP3
Similar videos
-
1:36
dr. chris twelves compares eribulin and capecitabine
-
1:38
dr. william gradishar discusses the eribulin and capecitabine 301 study
-
1:38
calgb 49907 trial: standard chemotherapy versus capecitabine for older women with breast cancer
-
6:39
capecitabine monotherapy doesn't improve survival in elderly patients with early-stage breast cancer
-
5:08
combination of capecitabine and bevacizumab improves progression-free survival in breast cancer
-
2:42
eribulin as treatment for metastatic breast cancer
-
13:11
capecitabine monotherapy doesn't improve survival in elderly patients with early-stage breast cancer
-
4:12
eribulin in recurrent metastatic er breast cancer
-
2:01
dr. edith perez on a phase iii trial comparing eribulin and capecitabine
-
20:37
the role of chemotherapy in the treatment of metastatic breast cancer patients
-
3:26
pd-1 therapy with eribulin for triple negative mbc
-
2:31
gut microbiome signatures correlate with os in pts receiving eribulin /- pembro for hr mbc
-
1:08
a study investigating pembrolizumab in combination with eribulin in tnbc
-
1:58
dr. twelves on a pooled analysis of eribulin in breast cancer
-
10:34
christopher twelves, md: comparing eribulin and capecitabine
-
2:28
comment: capecitabine for elderly early-stage breast cancer
-
11:28
recent data on eribulin in metastatic breast cancer patients from sabcs
-
2:13
dr. edith perez on study 301 that compared eribulin to capecitabine in mbc
-
4:42
results from adding adjuvant capecitabine to treatment for breast cancer patients